feed,title,long_url,short_url
Benzinga,Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study,https://benzinga.com/general/biotech/21/08/22629878/theravance-stock-plunges-as-jak-inhibitor-flops-ulcerative-colitis-study,https://j.mp/3zq4o0A
